Nakamuta M - Search Results

1

Feasibility and Efficacy of Endoscopic Ultrasound-Guided Hepaticogastrostomy Without Dilation: A Propensity Score Matching Analysis.

Ohno A, Fujimori N, Kaku T, Takamatsu Y, Matsumoto K, Murakami M, Teramatsu K, Takeno A, Hijioka M, Kawabe K, Harada N, Nakamuta M, Aso A, Oono T, Ogawa Y. Ohno A, et al. Among authors: nakamuta m. Dig Dis Sci. 2022 Dec;67(12):5676-5684. doi: 10.1007/s10620-022-07555-z. Epub 2022 Jun 10. Dig Dis Sci. 2022. PMID: 35689110

2

The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.

Nakamuta M, Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Yada M, Yada R, Takemoto R, Fukuizumi K, Harada N, Taketomi A, Maehara Y, Nakashima M, Enjoji M. Nakamuta M, et al. Int J Mol Med. 2008 Nov;22(5):663-7. Int J Mol Med. 2008. PMID: 18949388

3

Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.

Yasutake K, Nakamuta M, Shima Y, Ohyama A, Masuda K, Haruta N, Fujino T, Aoyagi Y, Fukuizumi K, Yoshimoto T, Takemoto R, Miyahara T, Harada N, Hayata F, Nakashima M, Enjoji M. Yasutake K, et al. Among authors: nakamuta m. Scand J Gastroenterol. 2009;44(4):471-7. doi: 10.1080/00365520802588133. Scand J Gastroenterol. 2009. PMID: 19058085

4

Early decline of the HCV core antigen can predict SVR in patients with HCV treated by Pegylated interferon plus ribavirin combination therapy.

Fujino T, Nakamuta M, Aoyagi Y, Fukuizumi K, Takemoto R, Yoshimoto T, Miyahara T, Harada N, Sakai H, Nakashima M, Enjoji M. Fujino T, et al. Among authors: nakamuta m. J Dig Dis. 2009 Feb;10(1):21-5. doi: 10.1111/j.1751-2980.2008.00358.x. J Dig Dis. 2009. PMID: 19236543

5

Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection.

Takemoto R, Nakamuta M, Aoyagi Y, Fujino T, Yasutake K, Koga K, Yoshimoto T, Miyahara T, Fukuizumi K, Wada Y, Takami Y, Saitsu H, Harada N, Nakashima M, Enjoji M. Takemoto R, et al. Among authors: nakamuta m. J Dig Dis. 2009 May;10(2):145-8. doi: 10.1111/j.1751-2980.2009.00377.x. J Dig Dis. 2009. PMID: 19426398

6

[A case of Cowden disease with a germline mutation in exon5 of PTEN gene diagnosed based on typical esophageal multiple polypoid lesions observed on a medical checkup].

Sawamura N, Harada N, Ihara E, Kakigao K, Sugi M, Haraguchi K, Mizutani T, Yoshimoto T, Kawabe K, Fukushima N, Fukuizumi K, Nakamuta M, Yoshimura R, Nakamura K. Sawamura N, et al. Among authors: nakamuta m. Nihon Shokakibyo Gakkai Zasshi. 2012 Apr;109(4):593-9. Nihon Shokakibyo Gakkai Zasshi. 2012. PMID: 22481260 Japanese.

7

[A case of protein-losing gastroenteropathy accompanied by Sjögren syndrome and mixed connective tissue disease].

Kakigao K, Fukushima N, Mizutani T, Haraguchi K, Okamoto R, Sawamura N, Oohashi T, Mitsuyasu A, Fujiyama T, Yoshimoto T, Koujima M, Kawabe K, Fukuizumi K, Nakamuta M, Harada N. Kakigao K, et al. Among authors: nakamuta m. Nihon Shokakibyo Gakkai Zasshi. 2012 Oct;109(10):1770-5. Nihon Shokakibyo Gakkai Zasshi. 2012. PMID: 23047635 Japanese.

8

Add-on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C.

Kohjima M, Enjoji M, Yoshimoto T, Yada R, Fujino T, Aoyagi Y, Fukushima N, Fukuizumi K, Harada N, Yada M, Kato M, Kotoh K, Nakashima M, Sakamoto N, Tanaka Y, Nakamuta M. Kohjima M, et al. Among authors: nakamuta m. J Med Virol. 2013 Feb;85(2):250-60. doi: 10.1002/jmv.23464. Epub 2012 Nov 14. J Med Virol. 2013. PMID: 23161429

9

Multigene analysis unveils distinctive expression profiles of helper T-cell-related genes in the intestinal mucosa that discriminate between ulcerative colitis and Crohn's disease.

Iboshi Y, Nakamura K, Ihara E, Iwasa T, Akiho H, Harada N, Nakamuta M, Takayanagi R. Iboshi Y, et al. Among authors: nakamuta m. Inflamm Bowel Dis. 2014 Jun;20(6):967-77. doi: 10.1097/MIB.0000000000000028. Inflamm Bowel Dis. 2014. PMID: 24739631 Clinical Trial.

10

Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.

Kohjima M, Yoshimoto T, Enjoji M, Fukushima N, Fukuizumi K, Nakamura T, Kurokawa M, Fujimori N, Sasaki Y, Shimonaka Y, Murata Y, Koyama S, Kawabe K, Haraguchi K, Sumida Y, Harada N, Kato M, Kotoh K, Nakamuta M. Kohjima M, et al. Among authors: nakamuta m. World J Gastroenterol. 2015 Mar 21;21(11):3291-9. doi: 10.3748/wjg.v21.i11.3291. World J Gastroenterol. 2015. PMID: 25805936 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page